Magnésium Ultra Fort 360 mg
Food supplement declared in France, declaration No 2024-4-1250, decision dated 24 April 2024
Magnésium Ultra Fort 360 mg (Forté Pharma) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Pantothenic acid (vitamin B5), Biotin (vitamin B8), Magnesium, Nicotinamide (vitamin B3), Vitamin B1 (thiamine). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- Forté Pharma
- Food business operator placing the product on the market
- Laboratoire FORTE PHARMA SA
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Tablet
- Daily dose
- 1 comprimé
- Directions for use
- Prendre 1 comprimé par jour, de préférence le matin, avec un grand verre d’eau (200 ml).
- Not recommended (according to the manufacturer)
- Adolescents (under 18), Breastfeeding women, Children (under 12), Pregnant women
- Objectives stated by the manufacturer (these are not authorised claims)
- Mood, Nervous system
Declaration 141185, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Other active ingredients
| Name | Per day |
|---|---|
| Taurine | not declared |
| L-Glutamine | not declared |
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| D-pantothenate, calcium | Pantothenic acid (vitamin B5) | no limit (insufficient data) | dose annulled by the French Council of State in 2011 |
| D-biotin | Biotin (vitamin B8) | no limit (insufficient data) | dose annulled by the French Council of State in 2011 |
| magnesium oxide | Magnesium | 250 mg | 300 mg |
| magnesium bisglycinate | Magnesium | 250 mg | 300 mg |
| magnesium salts of citric acid | Magnesium | 250 mg | 300 mg |
| nicotinamide | Nicotinamide (vitamin B3) | 900 mg | 54 mg |
| thiamin hydrochloride | Vitamin B1 (thiamine) | no limit (insufficient data) | dose annulled by the French Council of State in 2011 |
| methylcobalamin | Vitamin B12 | no adverse effect defined | dose annulled by the French Council of State in 2011 |
| Riboflavine 5'-phosphate | Vitamin B2 (riboflavin) | no limit (insufficient data) | dose annulled by the French Council of State in 2011 |
| pyridoxine hydrochloride | Vitamin B6 | 12 mg | 2 mg |
Additives
E464, E470b, E551, E471
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Label warnings
Un complément alimentaire ne doit pas se substituer à une alimentation variée et équilibrée et à un mode de vie sain. Tenir hors de portée des jeunes enfants. Ne pas dépasser la dose journalière conseillée. Déconseillé aux femmes enceintes et allaitantes et aux adolescents de moins de 18 ans sans avis médical. Une consommation excessive peut avoir des effets laxatifs. Ne pas associer avec d’autres compléments alimentaires qui apportent du magnésium. Ce complément alimentaire n’est pas un médicament.
Regulatory points
None of the rules we check applies to the declared ingredients.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Taurine
Read the warning, when it applies and the studies cited
TAURINE
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Lopez Ramon et al. 2007; Seghieri et al. 2007).
Sources cited by Health Canada (2)
- López Ramón Y Cajal C, Ocampo Martínez R, Couceiro Naveira E, Martínez M. Amino acids in amniotic fluid in the 15th-16th weeks of gestation and preterm labor. The Journal of Maternal-Fetal & Neonatal Medicine: the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. 2007;20(3):225-231.
- Seghieri G, Tesi F, Bianchi L, Loizzo A, Saccomanni G, Ghirlanda G, Anichini R, Franconi F. Taurine in women with a history of gestational diabetes. Diabetes Research and Clinical Practice 2007;76(2):187-192. PubMed
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
- L-Glutamine
Read the warning, when it applies and the studies cited
L-Glutamine
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Brand : Forté Pharma
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Magnésium Ultra Fort 360 mg (Forté Pharma): composition and regulation”, https://compoatlas.com/en/supplements/products/141185-magnesium-ultra-fort-360-mg, updated 15 November 2026.